tradingkey.logo

Alumis And Kaken Pharmaceutical Announce Collaboration And Licensing Agreement For ESK-001 In Dermatology In Japan

ReutersMar 25, 2025 8:03 AM

- Alumis Inc ALMS.O:

  • ALUMIS AND KAKEN PHARMACEUTICAL ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR ESK-001 IN DERMATOLOGY IN JAPAN

  • ALUMIS INC - TO RECEIVE $40 MILLION UPFRONT, POTENTIAL $140 MILLION IN MILESTONE PAYMENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI